Published in Oncogene on November 02, 2000
Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron (2003) 3.62
The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol (2003) 1.91
HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene (2001) 1.78
Papillomavirus E6 proteins. Virology (2008) 1.70
Oncogenic activities of human papillomaviruses. Virus Res (2009) 1.60
The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol (2010) 1.49
The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth. J Virol (2007) 1.40
Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol Cell Biol (2002) 1.38
Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J Virol (2004) 1.35
Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. J Virol (2007) 1.34
Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53. Structure (2012) 1.30
Requirement of PDZ-containing proteins for cell cycle regulation and differentiation in the mouse lens epithelium. Mol Cell Biol (2003) 1.27
Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J Virol (2006) 1.25
Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor. EMBO J (2006) 1.22
Cell polarity proteins: common targets for tumorigenic human viruses. Oncogene (2008) 1.22
Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells. J Cell Sci (2005) 1.22
Papillomavirus E6 oncoproteins. Virology (2013) 1.21
Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein. Oncogene (2003) 1.20
Link of the unique oncogenic properties of adenovirus type 9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2. EMBO J (2001) 1.18
The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase. J Virol (2005) 1.17
HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage. PLoS Pathog (2012) 1.16
A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles. J Virol (2007) 1.15
A mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo. J Virol (2002) 1.15
Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins. J Virol (2006) 1.14
The ESEV PDZ-binding motif of the avian influenza A virus NS1 protein protects infected cells from apoptosis by directly targeting Scribble. J Virol (2010) 1.13
Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses. J Virol (2011) 1.12
The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity. J Virol (2007) 1.11
Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11. J Virol (2004) 1.11
Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. PLoS Pathog (2011) 1.10
Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PLoS One (2010) 1.09
Junctional music that the nucleus hears: cell-cell contact signaling and the modulation of gene activity. Cold Spring Harb Perspect Biol (2009) 1.09
HPV E6, E6AP and cervical cancer. BMC Biochem (2008) 1.08
Evidence that the tandem-pleckstrin-homology-domain-containing protein TAPP1 interacts with Ptd(3,4)P2 and the multi-PDZ-domain-containing protein MUPP1 in vivo. Biochem J (2002) 1.08
E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein. J Virol (2006) 1.08
The avian influenza virus NS1 ESEV PDZ binding motif associates with Dlg1 and Scribble to disrupt cellular tight junctions. J Virol (2011) 1.07
E6 proteins from diverse papillomaviruses self-associate both in vitro and in vivo. J Mol Biol (2009) 1.05
The ubiquitin-specific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability. J Virol (2009) 1.00
Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. Arch Virol (2006) 1.00
Small molecule inhibitors of human papillomavirus protein - protein interactions. Open Virol J (2011) 0.97
Cell cycle regulation in the developing lens. Semin Cell Dev Biol (2006) 0.97
Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors. J Virol (2010) 0.97
Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes. J Virol (2007) 0.96
PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6. J Virol (2007) 0.95
The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose. Cell Death Differ (2005) 0.94
The role of protein kinase A regulation of the E6 PDZ-binding domain during the differentiation-dependent life cycle of human papillomavirus type 18. J Virol (2013) 0.94
The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species. PLoS Pathog (2013) 0.94
NFX1-123 increases hTERT expression and telomerase activity posttranscriptionally in human papillomavirus type 16 E6 keratinocytes. J Virol (2009) 0.93
Human viruses and cancer. Viruses (2014) 0.92
Putting into practice domain-linear motif interaction predictions for exploration of protein networks. PLoS One (2011) 0.92
The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein. J Virol (2009) 0.92
Cell-autonomous requirements for Dlg-1 for lens epithelial cell structure and fiber cell morphogenesis. Dev Dyn (2009) 0.92
Analysis of the PDZ binding specificities of Influenza A virus NS1 proteins. Virol J (2011) 0.91
Human tumour viruses and the deregulation of cell polarity in cancer. Nat Rev Cancer (2012) 0.90
HPV 5 and 8 E6 expression reduces ATM protein levels and attenuates LINE-1 retrotransposition. Virology (2013) 0.89
Several E4 region functions influence mammary tumorigenesis by human adenovirus type 9. J Virol (2001) 0.89
The critical protein interactions and structures that elicit growth deregulation in cancer and viral replication. Wiley Interdiscip Rev Syst Biol Med (2010) 0.88
The human adenovirus E4-ORF1 protein subverts discs large 1 to mediate membrane recruitment and dysregulation of phosphatidylinositol 3-kinase. PLoS Pathog (2014) 0.88
Papillomavirus E6 PDZ interactions can be replaced by repression of p53 to promote episomal human papillomavirus genome maintenance. J Virol (2013) 0.87
Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis. J Virol (2014) 0.87
E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus. J Virol (2009) 0.87
Cleavage of MAGI-1, a tight junction PDZ protein, by caspases is an important step for cell-cell detachment in apoptosis. Apoptosis (2007) 0.86
PDZ domains and viral infection: versatile potentials of HPV-PDZ interactions in relation to malignancy. Biomed Res Int (2013) 0.86
Biophysical characterization of the complex between human papillomavirus E6 protein and synapse-associated protein 97. J Biol Chem (2010) 0.85
The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy. Viruses (2015) 0.84
Functionally distinct monomers and trimers produced by a viral oncoprotein. Oncogene (2007) 0.84
Tight Junctions Go Viral! Viruses (2015) 0.84
An RNA Aptamer Targets the PDZ-Binding Motif of the HPV16 E6 Oncoprotein. Cancers (Basel) (2014) 0.83
NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity. J Virol (2010) 0.83
The PDZ1 and PDZ3 domains of MAGI-1 regulate the eight-exon isoform of the coxsackievirus and adenovirus receptor. J Virol (2012) 0.83
Regulation of the DLG tumor suppressor by β-catenin. Int J Cancer (2012) 0.83
Cancer-causing human papillomavirus E6 proteins display major differences in the phospho-regulation of their PDZ interactions. J Virol (2014) 0.81
Biomarkers in cervical cancer. Biomark Insights (2007) 0.81
PDZRN3/LNX3 is a novel target of human papillomavirus type 16 (HPV-16) and HPV-18 E6. J Virol (2014) 0.80
RNA interference for the treatment of papillomavirus disease. Open Virol J (2012) 0.80
Recent advances in the search for antiviral agents against human papillomaviruses. Antivir Ther (2007) 0.79
Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait? Pathogens (2016) 0.78
Drosophila MAGI interacts with RASSF8 to regulate E-Cadherin-based adherens junctions in the developing eye. Development (2015) 0.78
Regulation of interferon-β by MAGI-1 and its interaction with influenza A virus NS1 protein with ESEV PBM. PLoS One (2012) 0.77
A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin Receptor. PLoS Pathog (2016) 0.77
The role of ubiquitin and ubiquitin-like modification systems in papillomavirus biology. Viruses (2014) 0.76
The PDZ3 domain of the cellular scaffolding protein MAGI-1 interacts with the Coxsackievirus and adenovirus receptor (CAR). Int J Biochem Cell Biol (2015) 0.76
Adenovirus E4-ORF1 Dysregulates Epidermal Growth Factor and Insulin/Insulin-Like Growth Factor Receptors To Mediate Constitutive Myc Expression. J Virol (2015) 0.76
HPV-16 impairs the subcellular distribution and levels of expression of protein phosphatase 1γ in cervical malignancy. BMC Cancer (2015) 0.76
MAGI-1 Interacts with Nephrin to Maintain Slit Diaphragm Structure through Enhanced Rap1 Activation in Podocytes. J Biol Chem (2016) 0.76
Interaction of the Human Papillomavirus E6 Oncoprotein with Sorting Nexin 27 Modulates Endocytic Cargo Transport Pathways. PLoS Pathog (2016) 0.76
Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS). PLoS One (2014) 0.75
Magi Is Associated with the Par Complex and Functions Antagonistically with Bazooka to Regulate the Apical Polarity Complex. PLoS One (2016) 0.75
The differential role of HTRA1 in HPV-positive and HPV-negative cervical cell line proliferation. BMC Cancer (2016) 0.75
Sterile α Motif Domain Containing 9 Is a Novel Cellular Interacting Partner to Low-Risk Type Human Papillomavirus E6 Proteins. PLoS One (2016) 0.75
Transcriptomic analyses of genes differentially expressed by high-risk and low-risk human papilloma virus E6 oncoproteins. Virusdisease (2015) 0.75
Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins. Virology (2016) 0.75
Mitotic control of human papillomavirus genome-containing cells is regulated by the function of the PDZ-binding motif of the E6 oncoprotein. Oncotarget (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
SV40-transformed simian cells support the replication of early SV40 mutants. Cell (1981) 34.67
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell (1990) 20.60
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
The discs-large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions. Cell (1991) 5.30
The tight junction protein ZO-1 is homologous to the Drosophila discs-large tumor suppressor protein of septate junctions. Proc Natl Acad Sci U S A (1993) 3.48
Molecular characterization and tissue distribution of ZO-2, a tight junction protein homologous to ZO-1 and the Drosophila discs-large tumor suppressor protein. J Cell Biol (1994) 3.45
Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A (1997) 3.37
FAP-1: a protein tyrosine phosphatase that associates with Fas. Science (1995) 3.06
ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J Cell Biol (1998) 2.99
Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A (1997) 2.87
PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest (1999) 2.67
PDZ proteins organize synaptic signaling pathways. Cell (1998) 2.51
Cloning and characterization of hdlg: the human homologue of the Drosophila discs large tumor suppressor binds to protein 4.1. Proc Natl Acad Sci U S A (1994) 2.41
Molecular characterization and spatial distribution of SAP97, a novel presynaptic protein homologous to SAP90 and the Drosophila discs-large tumor suppressor protein. J Neurosci (1995) 2.40
Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line (CREF). Proc Natl Acad Sci U S A (1982) 2.36
Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene (1999) 2.25
The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci U S A (1996) 1.95
Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res (1993) 1.89
Subcellular targeting and cytoskeletal attachment of SAP97 to the epithelial lateral membrane. J Cell Sci (1998) 1.57
Adenovirus type 9 E4 open reading frame 1 encodes a transforming protein required for the production of mammary tumors in rats. J Virol (1994) 1.54
MAGI-1, a membrane-associated guanylate kinase with a unique arrangement of protein-protein interaction domains. J Biol Chem (1997) 1.51
Human adenovirus type 9-induced rat mammary tumors. J Virol (1991) 1.43
Human adenovirus early region 4 open reading frame 1 genes encode growth-transforming proteins that may be distantly related to dUTP pyrophosphatase enzymes. J Virol (1997) 1.39
Human adenovirus type 9 E4 open reading frame 1 encodes a cytoplasmic transforming protein capable of increasing the oncogenicity of CREF cells. J Virol (1996) 1.26
Functional expression of rat synapse-associated proteins SAP97 and SAP102 in Drosophila dlg-1 mutants: effects on tumor suppression and synaptic bouton structure. Mech Dev (1997) 1.24
Mutant adenovirus type 9 E4 ORF1 genes define three protein regions required for transformation of CREF cells. J Virol (1997) 1.20
Cytoplasmic localization of LIM-kinase 1 is directed by a short sequence within the PDZ domain. Exp Cell Res (1998) 1.14
Molecular characterization of a novel human PDZ domain protein with homology to INAD from Drosophila melanogaster. FEBS Lett (1997) 1.10
A carboxy-terminal region required by the adenovirus type 9 E4 ORF1 oncoprotein for transformation mediates direct binding to cellular polypeptides. J Virol (1997) 1.08
Early region 1 transforming functions are dispensable for mammary tumorigenesis by human adenovirus type 9. J Virol (1999) 1.00
Transformation and productive infection of human osteosarcoma cells by a feline sarcoma virus. Nat New Biol (1971) 0.83
Studies on the cleavage of bacteriophage lambda DNA with EcoRI Restriction endonuclease. J Mol Biol (1975) 19.67
Rapid DNA isolations for enzymatic and hybridization analysis. Methods Enzymol (1980) 11.28
Viable molecular hybrids of bacteriophage lambda and eukaryotic DNA. Proc Natl Acad Sci U S A (1974) 8.97
Functional selection and analysis of yeast centromeric DNA. Cell (1985) 7.74
Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis (1998) 7.51
Tracing European founder lineages in the Near Eastern mtDNA pool. Am J Hum Genet (2000) 7.06
Hybridization of RNA to double-stranded DNA: formation of R-loops. Proc Natl Acad Sci U S A (1976) 6.30
Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature (1998) 6.16
Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (1995) 6.03
Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol (1983) 5.07
Unique arrangement of coding sequences for 5 S, 5.8 S, 18 S and 25 S ribosomal RNA in Saccharomyces cerevisiae as determined by R-loop and hybridization analysis. J Mol Biol (1978) 5.02
Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem (1986) 4.80
Eukaryotic DNA segments capable of autonomous replication in yeast. Proc Natl Acad Sci U S A (1980) 4.73
Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chem Soc (2001) 4.28
A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer (1981) 4.25
Delineating Patterns of Medical Care. Am J Public Health Nations Health (1960) 4.11
Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res (2001) 3.94
Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J (1987) 3.81
Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J (1988) 3.81
Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med (2000) 3.74
Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol Cell Biol (2000) 3.37
Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol (1999) 3.35
Increased thrombotic vascular events after change of statin. Lancet (1998) 3.34
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med (1982) 3.16
Vitamin D concentrations in Asian children aged 2 years living in England: population survey. BMJ (1999) 3.14
Control of whooping cough in New Zealand; slow progress. N Z Med J (1995) 3.10
Carboxylation reactions and photosynthesis of carbon compounds in isolated mesophyll and bundle sheath cells of Digitaria sanguinalis (L.) Scop. Biochem Biophys Res Commun (1970) 3.05
Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect (2006) 3.04
The Brussels Declaration: the need for change in asthma management. Eur Respir J (2008) 2.91
Prospective study of the impact of fear of falling on activities of daily living, SF-36 scores, and nursing home admission. J Gerontol A Biol Sci Med Sci (2000) 2.89
Analysis of 150 patients with acute myocardial infarction admitted to an intensive care and study unit. Br Med J (1968) 2.88
Early results with the Lichtenstein tension-free hernia repair. Br J Surg (1994) 2.77
The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene (2001) 2.77
Home visits by an occupational therapist for assessment and modification of environmental hazards: a randomized trial of falls prevention. J Am Geriatr Soc (1999) 2.74
Investigation of the effects of coffee on alertness and performance during the day and night. Neuropsychobiology (1993) 2.62
Zein storage protein gene family of maize. An assessment of heterogeneity with cloned messenger RNA sequences. J Mol Biol (1982) 2.54
Differences in sexual risk behaviour between young men and women travelling abroad from the UK. Lancet (1998) 2.52
Haemodynamic effects of morphine in patients with acute myocardial infarction. Br Heart J (1965) 2.49
Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology (2007) 2.43
Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet (1999) 2.42
Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br J Dermatol (2013) 2.38
Biological control of locusts and grasshoppers. Annu Rev Entomol (2001) 2.34
Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis. Kidney Int (2008) 2.30
Spina bifida--and the parents. Dev Med Child Neurol (1971) 2.28
Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene (1999) 2.25
Physiological validation of the concept of glycemic load in lean young adults. J Nutr (2003) 2.20
Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis (1988) 2.20
Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology (1990) 2.17
Natural history and clinical significance of arrhythmias after acute cardiac infarction. Br Heart J (1967) 2.13
The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene (1999) 2.11
High-resolution characterization of herpes simplex virus type 1 transcripts encoding alkaline exonuclease and a 50,000-dalton protein tentatively identified as a capsid protein. J Virol (1983) 2.07
Glassy cell carcinoma of the uterine cervix. Cytologic features and expression of estrogen and progesterone receptors. Acta Cytol (2000) 2.05
Urinary excretion of free noradrenaline and adrenaline following acute myocardial infarction. Lancet (1967) 2.04
A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest (1997) 2.04
Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J Sci Am (1998) 2.03
Public knowledge, attitudes and behavior on antibiotic use: a telephone survey in Hong Kong. Infection (2008) 2.02
Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev (2000) 2.01
High speed laceration. Br Dent J (2008) 2.01
Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction. Am J Cardiol (1967) 1.98
Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol (2000) 1.97
Success of exchange reamed intramedullary nailing for femoral shaft nonunion or delayed union. J Orthop Trauma (2000) 1.95
Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc Natl Acad Sci U S A (1999) 1.93
Analysis of human p53 proteins and mRNA levels in normal and transformed cells. Eur J Biochem (1986) 1.91
Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol (1997) 1.91
Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart-failure in patients with acute myocardial infarction. Lancet (1969) 1.88
Study of antidiarrhoeal activity of four medicinal plants in castor-oil induced diarrhoea. J Ethnopharmacol (2001) 1.87
Endoscopic ultrasound-guided versus conventional transmural drainage for pancreatic pseudocysts: a prospective randomized trial. Endoscopy (2009) 1.87
Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras. EMBO J (1989) 1.84
Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med (2001) 1.84
Endoscopic removal of biliary self-expandable metallic stents: a prospective study. Endoscopy (2006) 1.83
Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol (2013) 1.79
Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene (1998) 1.78
HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene (2001) 1.78
Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. J Gen Virol (1987) 1.78
Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene (1992) 1.76
Heterospecific transformation in the genus Haemophilus. Mol Gen Genet (1984) 1.76
Eosinophilic meningitis caused by Angiostrongylus cantonensis: report of 17 cases. Am J Med (2001) 1.76
Circulatory changes associated with systemic hypotension in patients with acute myocardial infarction. Br Heart J (1966) 1.72
Iron status of Asian children aged 2 years living in England. Arch Dis Child (1998) 1.70
The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene (1992) 1.68
Hospital outbreak of clostridium perfringens food-poisoning. Lancet (1977) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Treatment of acute colonic pseudoobstruction (Ogilvie's syndrome) with cisapride. Gastroenterology (1990) 1.67
Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial. Cancer J Sci Am (1999) 1.67
Cardiac abnormalities in liver cirrhosis. West J Med (1989) 1.66
Heterotransplantation of human cancers into nude mice: a model system for human cancer chemotherapy. Cancer (1978) 1.64
Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother (2006) 1.64
CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr Biol (1997) 1.63
Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002. HIV Med (2006) 1.61
Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia. Br Heart J (1980) 1.60
Cocaine-induced potentiation of synaptic strength in dopamine neurons: behavioral correlates in GluRA(-/-) mice. Proc Natl Acad Sci U S A (2004) 1.60